Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
US8609650B2 · kind B2 · utility
9Cited by
12References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2011 |
| Grant date | Dec 17, 2013 |
| Priority date | — |
| Expiry date | Jul 26, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Bridged bicyclic aryl or heteroaryl substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the compounds in treating diseases or conditions associated with Axl activity are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.